Thrive Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Thrive Capital Management, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $43.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$43.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 22,943 | $5.6M |
| MRKMerck & Co., Inc. | 41,019 | $4.9M |
| UTHRUNITED THERAPEUTICS Corp | 7,152 | $4.2M |
| GILDGILEAD SCIENCES, INC. | 30,427 | $4.2M |
| NBIXNEUROCRINE BIOSCIENCES INC | 27,867 | $3.7M |
| LLYELI LILLY & Co | 3,911 | $3.6M |
| ELANElanco Animal Health Inc | 143,584 | $3.4M |
| ABTABBOTT LABORATORIES | 32,859 | $3.4M |
| HALOHALOZYME THERAPEUTICS, INC. | 51,632 | $3.3M |
| MMSIMerit Medical Systems Inc. | 48,230 | $3.3M |
| AMGNAMGEN INC | 4,490 | $1.6M |
| PMPhilip Morris International Inc | 3,328 | $550K |
| AZNASTRAZENECA PLC | 2,235 | $441K |
| ABBVAbbVie Inc. | 1,797 | $391K |
| CAHCardinal Health Inc. | 1,255 | $265K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.